FDA Inspection
BioDlogics LLCBioDlogics LLC – FDA Inspection, Aug 8, 2019
Record Details
This FDA Inspection record concerns BioDlogics LLC, with an inspection on August 8, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · e90959b5-1f5c-493e-bd47-a677dc4fdaa9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099499
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 1271.230(b)Reduced risk representation
- 21 CFR 1271.320(b)Sufficient information to draw conclusions
- 21 CFR 1271.350(a)(1)Adverse reaction reporting to FDA
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BioDlogics LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 11, 2026 | Not classified | New Orleans District Office | |
| January 27, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 5, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 27, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 17, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for BioDlogics LLC
- FDA Inspection 1325790 - 2026-06-11
- FDA Inspection 1001827 - 2017-01-27
- FDA Inspection 855595 - 2013-11-05
- FDA Inspection 781259 - 2012-04-27
- FDA Inspection 629528 - 2009-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.